Please login to the form below
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew
Three steps forward, four steps back
How to ensure digital content achieves the right dialogue
Real-world studies
by Bill Row
Is it time for a more integrated and human-centric approach to Medical Affairs leadership?
By Shairose Ebrahim
Rare disease trials Q&A
By Gretchen Goller and Valerie Legrand
-
Lonely planet: why there is dwindling value in pharma travelling aloneTo develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward
-
Accelerating diagnosis in rare diseaseBiopharmaceutical companies can drive effective partnerships and improve outcomes for all stakeholders and patients in the area of rare disease.
-
Accelerating innovationIpsen’s Alexandre Lebeaut on the French firm’s oncology plans, global focus and R&D approach
-
Janssen’s quest to prevent diseases taking holdJohan van Hoof, general manager of Janssen Vaccines & Prevention, on 'recalibrating' public understanding of illness
-
Opening up innovationPaul-Peter Tak on GlaxoSmithKline’s R&D strategy and the pivotal role of immunology
-
Transformational technologyBig data, the cloud and the value of insights
Featured jobs
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
-
Consultant
-
competitive salary
- Account Director or Senior Account Director
-
Salary TBC
-
Vice President
-
Competitive Salary Offered
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
Subscribe to our email news alerts
- New coronavirus sees drug developers scramble to develop a vaccine
- Moving annual total (MAT)
- Novartis links up with NHS for speedy access to cholesterol drug inclisiran
- Immuno-oncology, personalised medicine continues to drive pharma sector
- Roche's checkpoint inhibitor fails pivotal urothelial cancer trial
- NICE knocks back AstraZeneca's Tagrisso again
- Data desires
- TBWA\WorldHealth London announces restructure and key hires
- WHITE PAPER: Marketing fulfilment – a balancing act
- AZ, Daiichi Sankyo’s Enhertu set fair for filing in gastric cancer
- Roche files Tecentriq/Avastin combo in liver cancer
- New coronavirus sees drug developers scramble to develop a vaccine
PMHub
Pegasus
Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...
Latest intelligence
- Data desires
- What are you looking to achieve with data and how are you preparing yourself to react to the results?...
- The balancing act that’s keeping pharma and biotech market access on its toes
- Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
- Tackling antimicrobial resistance on multiple fronts
- An urgent change of direction is needed in how we respond to AMR...
Quick links
Infographics
